世界中医药
文章摘要
引用本文:匡梦华,陈焱,马珏,潘漪莲,郭玉娜.丹参滴注液治疗胎儿宫内生长受限的临床治疗分析[J].世界中医药,2016,(03):.  
丹参滴注液治疗胎儿宫内生长受限的临床治疗分析
Observation on Clinical Effects of Danshen Infusion in the Treatment of Fetal Growth Restriction
投稿时间:2015-04-02  
DOI:10.3969/j.issn.1673-7202.2016.03.014
中文关键词:  丹参滴注液  胎儿生长受限  临床疗效
English Keywords:Danshen infusion  Fetal growth restriction  Clinical efficacy
基金项目:
作者单位
匡梦华,陈焱,马珏,潘漪莲,郭玉娜 上海交通大学医学院附属国际和平妇幼保健院上海200030 
摘要点击次数: 1159
全文下载次数: 1432
中文摘要:
      目的:观察丹参滴注液治疗胎儿生长受限的临床疗效。方法:选择诊断为胎儿生长受限并接受治疗并住院分娩孕妇80例,随机分为2组:治疗组40例,对照组40例;正常孕妇40例为正常组,观察治疗前后宫高、腹围、双顶径、股骨长增长幅度,脐血流指标(S/D、PI、RI)变化情况,并比较出生时Apgar评分及体重情况。结果:1)治疗后,治疗组宫高、腹围、BPD及FL治疗前后增长值明显高于对照组,有明显统计学意义(P<0.05);2)治疗后,治疗组脐血流治疗(S/D、PI、RI)低于对照组,有明显统计学意义(P<0.05);3)治疗组出生体重高于对照组(P<0.05),但仍低于正常组。结论:丹参滴注液能够有效治疗胎儿宫内生长受限。
English Summary:
      To study the clinical efficacy of Shendan infusion in treating fetal growth restriction(FGR). Methods: A total of 80 pregnant women who were diagnosed of FGR in our hospital were divided into treatment group and control group, with 40 cases in each group. Also, there were 40 cases of normal pregnant women composed of normal group. To observe the uterine height, abdominal circumference, fetal biparietal diameter, femur length and umbilical blood flow indicators (S/D、PI、RI) of the control group and treatment group weekly before and after the treatment and to compare the weight and Apgar score at birth. Results: 1)The increase of the uterine height, abdominal circumference, biparietal diameter, femur length in the treatment group are higher than those of the control group(P<0.05). 2) After treatment, S/D、PI、RI of the treatment group are lower than that of the control group(P<0.05). 3) The birth weight of the treatment group is higher than that of the control group but lower than normal group(P<0.05). Conclusion: Danshen infusion is effective on the treatment of FGR.
查看全文  查看/发表评论  下载PDF阅读器